VRCA vs XPEV · rev $10.9M vs rev $895.7M
Verrica Pharmaceuticals Inc (VRCA) versus Xpeng Inc (XPEV) — a side-by-side from cached financials, not a winner call.
Verrica Pharmaceuticals Inc (VRCA) is a biotechnology company listed on US.
Xpeng Inc (XPEV) is a auto manufacturers company listed on US. It is led by Xiaopeng He.
Latest reported VRCA revenue for 2026-06-30 was $10.9M. Net income was -$22.8M. VRCA currently screens at market cap $79.7M.
Latest reported XPEV revenue for 2020-12-31 was $895.7M. Net income was -$418.7M. XPEV currently screens at market cap $20.28B.
VRCA currently screens at market cap $79.7M. XPEV currently screens at market cap $20.28B.
Not investment advice. Open the VRCA and XPEV stock pages for the full models.
Not investment advice.